Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 705 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the Financial year ended March 31, 2026.
Regulatory Filings Classification · 95% confidence The document is titled “Annual Secretarial Compliance Report for the financial year ended March 31, 2026” and is addressed to stock exchanges under SEBI Listing Regulations. It is a detailed compliance certificate issued by a firm of Company Secretaries confirming the company’s adherence to statutory provisions and listing obligations. It does not present financial performance (so not a 10-K, IR, ER, etc.), nor is it an AGM presentation, call transcript, or proxy statement. It is a regulatory compliance filing and falls under the general regulatory announcements and compliance documents category.
2026-05-27 English
Earnings Call Transcript - Q4FY26.
Call Transcript Classification · 95% confidence The document is a full transcript of Neogen Chemicals Limited’s Q4 FY26 earnings conference call, including opening remarks by management, detailed financial discussion, and a Q&A session. It clearly constitutes a full call transcript rather than a brief earnings release or presentation. According to the category definitions, this is a Call Transcript (CT).
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is the full transcript of Neogen Chemicals Limited’s Q4 FY26 earnings conference call, containing leadership remarks, CFO presentation, and Q&A. It is not the initial earnings release (ER) but a detailed call transcript. Therefore, it falls under Call Transcript (CT).
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 80% confidence The document is a letter to stock exchanges under SEBI Listing Regulations disclosing the outcome of an earnings conference call and providing a link to the audio recording. It does not contain actual financial results, a full transcript, nor detailed report content—merely a compliance announcement of the call recording availability. Therefore, it fits the “Regulatory Filings” fallback category.
2026-05-18 English
Earning''s conference call recording - Q4FY26.
Regulatory Filings Classification · 80% confidence The document is a brief notice to stock exchanges disclosing the availability of an earnings conference call audio recording on the company’s website, filed under Regulation 30 of SEBI (LODR). It does not include the full transcript or substantive financial data, nor is it itself a financial report or presentation. It is a regulatory disclosure announcement, best classified as a general Regulatory Filing (RNS).
2026-05-18 English
Press Release
Earnings Release Classification · 87% confidence The document is a press release announcing the audited financial results (standalone and consolidated) for the quarter and full year ended March 31, 2026, with key financial highlights, commentary, and operational updates. It does not contain full financial statements or detailed analysis typical of an Interim/Quarterly Report (IR), nor is it announcing the publication of a report. It matches the definition of an Earnings Release (ER) — the initial announcement of quarterly/periodical results with key metrics. Q4 2026
2026-05-17 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.